Detalles de la búsqueda
1.
Determining clinically important differences in health-related quality of life in older patients with cancer undergoing chemotherapy or surgery.
Qual Life Res
; 28(3): 663-676, 2019 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-30511255
2.
Adherence to geriatric assessment-based recommendations in older patients with cancer: a multicenter prospective cohort study in Belgium.
Ann Oncol
; 29(9): 1987-1994, 2018 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29905766
3.
Relevance of a systematic geriatric screening and assessment in older patients with cancer: results of a prospective multicentric study.
Ann Oncol
; 24(5): 1306-12, 2013 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-23293115
4.
A Belgian Survey on Geriatric Assessment in Oncology Focusing on Large-Scale Implementation and Related Barriers and Facilitators.
J Nutr Health Aging
; 20(1): 60-70, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26728935
5.
Rivizor--a new third-generation aromatase inhibitor for the treatment of advanced breast cancer after tamoxifen failure.
Oncology
; 56(2): 114-21, 1999.
Artículo
en Inglés
| MEDLINE | ID: mdl-9949297
6.
Clinical efficacy and endocrine activity of vorozole in postmenopausal breast cancer patients. Results of a multicentric phase II study.
Ann Oncol
; 8(8): 745-50, 1997 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-9332681
7.
Vorozole (Rivizor): an active and well tolerated new aromatase inhibitor for the treatment of advanced breast cancer patients with prior tamoxifen exposure. Investigational Drug Branch of the European Organization for Research and Treatment of Cancer (EORTC) Breast Cancer Cooperative Group.
Anticancer Drugs
; 9(1): 29-35, 1998 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-9491789
8.
Diagnostic value of fiberbronchoscopy in immunocompromised, haematologic patients with pulmonary infiltrates.
Acta Clin Belg
; 42(5): 323-9, 1987.
Artículo
en Inglés
| MEDLINE | ID: mdl-3425118
Resultados
1 -
8
de 8
1
Próxima >
>>